SYSMEX CORP.UNSP.ADR 1/2 (0YX0) - Total Liabilities
Based on the latest financial reports, SYSMEX CORP.UNSP.ADR 1/2 (0YX0) has total liabilities worth €186.25 Billion EUR (≈ $217.75 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are SYSMEX CORP.UNSP.ADR 1/2's assets to evaluate the company's liquid asset resilience ratio.
SYSMEX CORP.UNSP.ADR 1/2 - Total Liabilities Trend (2022–2025)
This chart illustrates how SYSMEX CORP.UNSP.ADR 1/2's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 0YX0 total asset value.
SYSMEX CORP.UNSP.ADR 1/2 Competitors by Total Liabilities
The table below lists competitors of SYSMEX CORP.UNSP.ADR 1/2 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Temenos Group AG
SW:TEMN
|
Switzerland | CHF1.77 Billion |
|
AUTO1 Group SE
F:AG1
|
Germany | €2.31 Billion |
|
Tamarack Valley Energy Ltd
TO:TVE
|
Canada | CA$1.64 Billion |
|
United Internet AG NA
XETRA:UTDI
|
Germany | €6.67 Billion |
|
Castech Inc
SHE:002222
|
China | CN¥726.63 Million |
|
Torex Gold Resources Inc
TO:TXG
|
Canada | CA$486.90 Million |
|
Xian Sunresin New Materials Co Ltd
SHE:300487
|
China | CN¥2.13 Billion |
|
Synnex Technology International Corp
TW:2347
|
Taiwan | NT$129.68 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down SYSMEX CORP.UNSP.ADR 1/2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 0YX0 net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SYSMEX CORP.UNSP.ADR 1/2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SYSMEX CORP.UNSP.ADR 1/2 (2022–2025)
The table below shows the annual total liabilities of SYSMEX CORP.UNSP.ADR 1/2 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €200.73 Billion ≈ $234.68 Billion |
+7.91% |
| 2024-03-31 | €186.02 Billion ≈ $217.48 Billion |
+30.34% |
| 2023-03-31 | €142.72 Billion ≈ $166.85 Billion |
+5.99% |
| 2022-03-31 | €134.65 Billion ≈ $157.42 Billion |
-- |
About SYSMEX CORP.UNSP.ADR 1/2
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more